snc logo
AI Search Beta
Search Limit Reached
To ensure smooth performance and fair access for all users, AI searches are limited within a set timeframe. Please try again later.
Companies
Add Entity
snc-logo

Startup Nation Finder

My Watchlists
Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
Saved Searches
Following
Messaging
Notifications
About Us
Glossary

Your CSV is on the way

We’ve sent your CSV file to
send file

Provide your business email

To complete this action, please provide your Business email.

Verify your business email

You only need to verify it once.
We’ve sent a verification link to

Create Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
0/300
Notifications Settings
Public content (accessible by all Finder users)

Add to List

    Notifications settings

    Set Notifications
    Off
    Select notifications to recieve tooltip-info
    Select all

    Email Alerts

    Receive notifications via email

    No Notifications are selected

    Would you like to select any notifications?
    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Create Free Account
    Lock Icon
    Lock Icon
    8 Characters, Uppercase letter (A-Z),
    Lowercase letter (a-z), Digit (0-9)
    Lock Icon
    Passwords do not match
    Already have an account? Sign In
    Or continue with

    Verify your email

    We’ve sent a verification link to [email protected]
    Sign in
    Lock Icon
    Lock Icon
    Reset password
    Don't have an account? Create Account
    Or continue with

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    disclaimer-icon
    Summary generated by AI
    Read article
    snackbar-icon
    title
    message
    Search Startups

    Stage B and Stage Acquired, Drugs Discovery & Development Startups

    Filters
    Clear

    Search by tag 

    All of
    Any of
    None of

    Sector (1)

    Primary Sector 

    Target Customer 

    Core Technology 

    Funding Stage (2)

    Founded 

    From
    To

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models 

    Product Stage 

    Employees 

    Location 

    Status 
    Processing your search... This may take a moment
    42 Startups 0 In the News 0 Recently Updated
    • Total Funding
      $3.65B
      Raised
      94
      Events
    • Private Funding
      $1.02B
      Raised
      43
      Rounds
    • Public Offerings
      $531.71M
      Raised
      20
      Offerings
    • M&A
      $2.1B
      Raised
      31
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags
    Anchiano Therapeutics logo

    Anchiano Therapeutics

    PRESUMED INACTIVE
    Targeted Cancer Therapies Based on H19 Gene
    2004 B2B 1-10 Acquired $37.7M
    cancer
    biotechnology
    biopharmaceutical
    cell-therapy
    biopsy
    targeted-therapy
    pharma-companies
    Applied Immune Technologies logo

    Applied Immune Technologies

    PRESUMED INACTIVE
    TCRL Antibodies for Therapeutic Applications
    2006 B2B 1-10 Acquired $4.4M
    viral-diseases
    cancer
    antibodies
    biotechnology
    biopharmaceutical
    therapeutics
    diagnostics
    autoimmune-diseases
    patients
    doctors
    Ayala Pharmaceuticals logo

    Ayala Pharmaceuticals

    Acquired
    Targeted Therapies for People with Rare Cancers
    2017 B2B 11-50 Acquired $102M
    rare-diseases
    cancer
    genomics
    cell-therapy
    drug-discovery
    oncology
    therapeutics
    pharmaceuticals
    life-sciences
    patients
    BioSight logo

    BioSight

    PRESUMED INACTIVE
    Therapeutics for Oncology and Hematological Disorders
    1999 B2B 1-10 Acquired $62.5M
    chemotherapy
    cancer
    drug-discovery
    biopharmaceutical
    targeted-therapy
    pharmaceuticals
    cancer-therapy
    oncology
    hematology
    BTG logo

    BTG

    Acquired
    Genetically Engineered Drugs
    1980 B2B2C 201-500 Acquired $26.93M
    eye-diseases
    ophthalmology
    genetic-engineering
    osteoarthritis
    biotechnology
    biopharmaceutical
    patients
    pharma-companies
    cCAM Biotherapeutics logo

    cCAM Biotherapeutics

    PRESUMED INACTIVE
    Monoclonal Antibodies for Cancer Treatment
    2010 B2B 1-10 Acquired $8M
    therapeutics
    cancer
    pharmaceuticals
    immunology
    treatments
    pharma-companies
    Cellect Biotechnology logo

    Cellect Biotechnology

    PRESUMED INACTIVE
    Immune System Regeneration
    2011 B2B 11-50 Acquired $24.26M
    therapeutics
    immunology
    regenerative-medicine
    cell-therapy
    bioprocess
    biotechnology
    medical-technologies
    stem-cells
    chronic-patients
    cancer
    medical-devices
    academia
    cancer-therapy
    diabetes
    pharma-companies
    laboratories
    healthcare-providers
    Processing your search... This may take a moment
    Startup AI Search Beta
    Search notes

    Search Startups

    42 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $3.65B
      Raised
      94
      Events
    • Private Funding
      $1.02B
      Raised
      43
      Rounds
    • Public Offerings
      $531.71M
      Raised
      20
      Offerings
    • M&A
      $2.1B
      Raised
      31
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    Anchiano Therapeutics logo
    Raised
    $37.7M
    Anchiano Therapeutics
    PRESUMED INACTIVE
    Targeted Cancer Therapies Based on H19 Gene
    Founded:2004
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    Applied Immune Technologies logo
    Raised
    $4.4M
    Applied Immune Technologies
    PRESUMED INACTIVE
    TCRL Antibodies for Therapeutic Applications
    Founded:2006
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    Ayala Pharmaceuticals logo
    Raised
    $102M
    Ayala Pharmaceuticals
    Acquired
    Targeted Therapies for People with Rare Cancers
    Founded:2017
    Business Model:B2B
    Employees:11-50
    Funding Stage:Acquired
    BioSight logo
    Raised
    $62.5M
    BioSight
    PRESUMED INACTIVE
    Therapeutics for Oncology and Hematological Disorders
    Founded:1999
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    BTG logo
    Raised
    $26.93M
    BTG
    Acquired
    Genetically Engineered Drugs
    Founded:1980
    Business Model:B2B2C
    Employees:201-500
    Funding Stage:Acquired
    cCAM Biotherapeutics logo
    Raised
    $8M
    cCAM Biotherapeutics
    PRESUMED INACTIVE
    Monoclonal Antibodies for Cancer Treatment
    Founded:2010
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    Cellect Biotechnology logo
    Raised
    $24.26M
    Cellect Biotechnology
    PRESUMED INACTIVE
    Immune System Regeneration
    Founded:2011
    Business Model:B2B
    Employees:11-50
    Funding Stage:Acquired
    Access Comprehensive Financial Analytics
    Create a free account to:
    • Explore detailed financial analytics.
    • Track company growth and size.
    • Connect with company team members.
    I already have access,
    I already have access,